Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
As the pharmaceutical industry continues to learn about COVID-19, IQVIA has called upon its experience with patient registries and analytics to create a direct-to-patient registry. The CARE Registry aims to
Track symptom presentation, severity, and the progression of COVID-19 in the general population
Monitor the treatments patients are using for COVID-19, as well as for other pre-existing conditions
Provide reference or context for product safety studies
Link CARE project data to other real world data sources to provide richer findings and insights